Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
13.84
+0.05 (0.36%)
At close: Aug 28, 2026, 4:00 PM EDT
13.84
0.00 (0.00%)
Pre-market: Aug 31, 2026, 8:50 AM EDT

Bioventus Revenue

Bioventus had revenue of $153.21M in the quarter ending June 27, 2026, with 3.76% growth. This brings the company's revenue in the last twelve months to $581.85M, up 3.14% year-over-year. In the year 2025, Bioventus had annual revenue of $568.09M, down -0.91%.

Revenue (ttm)
$581.85M
Revenue Growth
+3.14%
P/S Ratio
2.00
Revenue / Employee
$612,472
Employees
950
Market Cap
1.16B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025568.09M-5.19M-0.91%
Dec 31, 2024573.28M60.94M11.89%
Dec 31, 2023512.35M228.00K0.04%
Dec 31, 2022512.12M81.22M18.85%
Dec 31, 2021430.90M109.74M34.17%
Dec 31, 2020321.16M-18.98M-5.58%
Dec 31, 2019340.14M20.96M6.57%
Dec 31, 2018319.18M65.53M25.83%
Dec 31, 2015253.65M10.76M4.43%
Dec 31, 2014242.89M10.52M4.53%
Dec 31, 2013232.38M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.